Partnership to Improve Patient Care

  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Action Center
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • News
    • Press Releases
    • PIPC in the News
    • PIPC Weekly Update
    • PIPC Patients' Blog
    • Chairman's Corner
    • The Data Mine
  • Events
    • Nevada AB 259
    • QALY Panel
    • QALY Briefing
    • Past Webinars >
      • MFN/IPI Webinar 2025
      • Discrimination & Health Care
      • C & GT Webinar
      • ICER COVID Webinar
      • Value Our Health Briefing
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Action Center
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • News
    • Press Releases
    • PIPC in the News
    • PIPC Weekly Update
    • PIPC Patients' Blog
    • Chairman's Corner
    • The Data Mine
  • Events
    • Nevada AB 259
    • QALY Panel
    • QALY Briefing
    • Past Webinars >
      • MFN/IPI Webinar 2025
      • Discrimination & Health Care
      • C & GT Webinar
      • ICER COVID Webinar
      • Value Our Health Briefing
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010

Resource Center

PIPC Submits Letter in Support of MA Bill to Ban QALYs

5/14/2025

 
​PIPC submitted written testimony in Massachusetts supporting S. 465. S. 465 includes language that would bar the use of the discriminatory quality-adjusted life year (QALY) and similar metrics. The language mirrors the language barring the QALY and similar metrics included in Medicare. The bill includes several other critical patient protections, including requirements for patient centered research and a physical override mechanism. 
Dear Chair Jehlen, Chair Stanley and Members of the Joint Committee on Elder Affairs:

I am writing on behalf of the Partnership to Improve Patient Care (PIPC) to express support for S. 465, An Act supporting individuals suffering with amyotrophic lateral sclerosis and their families. This bill includes critical protections against discrimination in health care for people with disabilities and chronic illnesses. Passing this bill would mark a critical step in curbing the discrimination people with disabilities and chronic illnesses have long experienced in health care.

S. 465 would enshrine essential patient protections including: a ban on the use of the Quality-Adjusted Life Year (QALY) and similar measures, a requirement for Massachusetts to rely on research that meets criteria of patient-centeredness, robust engagement with patients and people with disabilities, and an appeals and physician override mechanism. These are critically important provisions to ensure people with disabilities and chronic illnesses are able to access the care they need without discriminatory barriers.

Assessments based on QALYs and similar measures assign a financial value to health improvements provided by a treatment that do not account for outcomes that matter to people living with the relevant health condition and that attribute a lower value to life lived with a disability. When applied to health care decision-making, the results can mean that people with disabilities and chronic illnesses, including older adults, are deemed not worth the cost to treat. For decades, the patient and disability communities have opposed the use of the discriminatory QALY to determine cost effectiveness or “value” of treatments. The National Council on Disability (NCD), an independent federal agency, concluded in a 2019 report that QALYs place a lower value on treatments which extend the lives of people with chronic illnesses and disabilities. NCD recommended that policymakers and insurers reject QALYs, concluding the use of the QALY would be contrary to United States disability policy and civil rights laws.

The United States has a thirty-year, bipartisan track record of opposing the use of the QALY and similar discriminatory metrics and has established appropriate legal safeguards to mitigate their use. Section 504 of the Rehabilitation Act ensures that people with disabilities will not be “excluded from participation in, be denied the benefits of, or otherwise be subjected to discrimination,” under any program offered by any Executive Agency, including Medicare, with new regulations explicitly barring use of discriminatory value assessments in decisions impacting access to care. Title II of the Americans with Disabilities Act (ADA) extended this protection to programs and services offered by state and local governments. Following the ADA’s passage in 1990, HHS rejected a state waiver application in 1992 because its reliance on QALYs and cost effectiveness standards would have violated the ADA and led to discrimination against people with disabilities in determining the state’s prioritized list of services.

In 2010, the Affordable Care Act (ACA) prohibited QALYs and similar metrics from being used by HHS as a threshold to establish what type of health care is cost effective or recommended, as well as prohibiting their use as a threshold in Medicare to determine what is covered, reimbursed or incentivized.

Much to our concern, despite this clear precedent, QALYs continue to be referenced in health care policies. It is particularly concerning that the Massachusetts Health Policy Commission is working with the Institute for Clinical and Economic Review (ICER), which is on record stating that QALYs are the “gold standard.” To mitigate against use of ICER’s assessments or assessments using a similar QALY-based methodology to dictate access to care in Massachusetts, it is imperative that strong patient protections are codified into law.
An Act supporting individuals suffering with amyotrophic lateral sclerosis and their families would address these issues and mitigate use of discriminatory value assessments against residents of Massachusetts living with disabilities.

Sincerely,
​
Thayer Surette Roberts
Deputy Director
Partnership to Improve Patient Care 
ma_s._465_2025_final_for_submission_.pdf
File Size: 219 kb
File Type: pdf
Download File


Comments are closed.

    Topics

    All
    Advocacy
    Alternative Payment Models
    Letters And Comments
    Patient Centered Research
    Patient-Centered Research
    PCORI Meeting Transcripts
    Polling
    Roundtables
    Value Frameworks
    White Papers

    Archives

    June 2025
    May 2025
    April 2025
    February 2025
    January 2025
    October 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    February 2024
    January 2024
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    May 2022
    April 2022
    March 2022
    February 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    July 2020
    June 2020
    May 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    March 2018
    November 2017
    October 2017
    September 2017
    July 2017
    June 2017
    May 2017
    April 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    June 2016
    May 2016
    April 2016
    March 2016
    January 2016
    December 2015
    November 2015
    September 2015
    July 2015
    June 2015
    May 2015
    April 2015
    February 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    February 2014
    January 2014
    November 2013
    October 2013
    September 2013
    July 2013
    May 2013
    December 2012
    November 2012
    October 2012
    September 2012
    May 2012
    March 2012
    January 2012
    December 2011
    September 2011
    July 2011
    May 2011
    April 2011
    March 2011
    November 2010
    August 2010
    July 2009
    June 2009

Powered by Create your own unique website with customizable templates.